课题基金 / 基金详情

Statins as adjuncts to first-line therapy for tuberculosis disease

Statins as adjuncts to first-line therapy for tuberculosis disease
他汀类药物作为结核病一线治疗的辅助药物
批准号：
461432
负责人：
Brassard Paul
金额：
$11.7万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-03-01 至 2024-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=461432&lang=en
关键词：
Adjunctive Therapy Cohort Study Pharmacoepidemiology Statins Tuberculosis Disease

项目摘要

项目成果

Brassard Paul的其他基金

相似基金

相关文献

中文摘要
翻译
结核病是一个严重的全球健康威胁，每年夺去数百万人的生命。虽然可以治愈，但分枝杆菌对抗生素的抗药性可能会产生。此外，延长的治疗时间、药物毒性和存在
英文摘要
Tuberculosis (TB) disease is a serious global health threat claiming millions of lives every year. Although curable, resistance of Mycobacterium bacteria to antibiotics may develop. In addition, prolonged duration of treatment, drug toxicity and presence
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease
Illiap Paanganik Qaujisarniq: Adapting Cervical Cancer Screening Strategies for Inuit Women of Nunavik
Illiap Paanganik Qaujisarniq: Tailoring Cervical Cancer Screening Services for Inuit Women of Nunavik
Working with Inuit communities to improve cervical cancer screening coverage in Nunavik, Quebec
海外基金